Brunilda Shtylla

Brunilda Shtylla, M.B.A., M.S.

Chief Business Officer

Brunilda Shtylla M.B.A., M.S. has over 20 years of cross-functional experience in biotech and medical devices including business development, investment banking, product development and operations. At Sutro, Ms. Shtylla has successfully executed several licensing and collaboration deals. She was instrumental in the Merck cytokine collaboration, Astellas iADC collaboration, Vaxcyte manufacturing agreement and regional licensing deals. Prior to this, from 2012 until 2020, Ms. Shtylla was an independent consultant to several companies including Genentech, GRAIL and Edward Lifesciences. In addition, she advised several start-up companies in assessing market size opportunities, supporting due diligence analysis, negotiating licensing and supply agreements. From 2003-2011, she held numerous positions at Lifescan, a Johnson & Johnson company in Business Development, Technology Transfer, Product Development, Sales & Operations Planning and U.S. Brand Marketing with the most recent role being Associate Director of Partnerships.

Ms. Shtylla’s previous experiences also include investment banking and finance. She received her B.S. from Wayne State University, an M.S. in Mathematics from Youngstown State University and an M.B.A. from Stanford Graduate School of Business.